Hosted by Dr. Léorah Freeman, the episode highlights the inspiring work and collaboration between a start-up and academia, bringing together expertise in MS research, neuro-optometry, and optical engineering, to address some of the big unmet needs in MS care: progression independent of relapse (PIRA). Featuring Dr. Christy Sheehy (CEO of C. Light Technologies), Dr. Jacqueline Theis (neuro-optometrist and Chief Medical Officer), and Dr. Ari Green (Professor of Neurology at UCSF), the discussion highlights their project—a study on a novel quantitative oculomotor biomarker based on small retinal eye movements. This biomarker holds the promise of enabling earlier and more precise detection of PIRA.

The conversation delves deeper into the value of investigating eye movements and other biomarkers, emphasizing their importance in tracking disease progression and advancing precise diagnostic tools. Listen now and be inspired by their journey—from starting with academic research to founding a successful startup and building larger collaborations.

Together they have been working to design a solution for transformative advances in the MS field to help patients and their carers.